nach oben

Erschienen in:

01.09.2023 | Clinical study

Triple therapy as safe as dual therapy for elephantiasis prevention

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Triple therapy with ivermectin, diethylcarbamazine and albendazole (IDA) appears to be as safe as dual therapy with diethylcarbamazine and albendazole (DA) as the standard mass drug administration (MDA) regimen for the prevention of lymphatic filariasis (elephantiasis), et al. neglected tropical disease (NTD), according to findings of a safety surveillance study published in Drug Safety . …

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study Drug Safety : 8 Aug 2023. Available from: URL: https://doi.org/10.1007/s40264-023-01338-9

Titel: Triple therapy as safe as dual therapy for elephantiasis prevention
Publikationsdatum: 01.09.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-45393-5

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Triple therapy as safe as dual therapy for elephantiasis prevention

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Dapagliflozin

Dr. Berne's recalls eye drops and mist due to contamination

Multiple drugs

Amiodarone

Baclofen

Baclofen/diazepam/metoclopramide